Global, regional, and national burden of non-COVID-19 lower respiratory infections and risks, 1990–2023: a systematic analysis from GBD Study 2023

Caini Mu, Feng Liu, Lei Miao, Mengling Feng, Xiangyu Dang, Lixin Xie, Shanhong Fan, Li XuanResearch Square 2025 · DOI

Abstract

Background: Despite global progress in vaccination, antibiotic use, and sanitation, lower respiratory infections (LRIs) remain a substantial global burden. This study uses Global Burden of Disease 2023 data to inform LRIs control. Methods: We quantified global and regional incidence, mortality, and DALYs for non-COVID-19 LRIs from 1990–2023, and assessed risks to LRI DALYs and deaths. Results: In 2023, global LRI incidence was 3,012.84 per 100,000, down since 1990 (AAPC −1.57%). Africa had the highest incidence (5,848.11). By age, the ≥ 70 group had the highest incidence, followed by under-5s. Leading risk factors were child underweight and household air pollution. Conclusions: The LRI burden declined 1990–2023, but disparities persist. Addressing child nutrition and air quality is critical for health equity.

Introduction: The Persistent Threat of LRIs

Lower respiratory infections (LRIs), including pneumonia and bronchiolitis, have historically been leading causes of death and disability globally. While the introduction of pneumococcal and influenza vaccines has mitigated some of this impact, LRIs continue to impose significant health and economic costs.

Existing research often focuses on narrow demographics, such as children under five, or specific geographic regions. This study addresses the need for a comprehensive, longitudinal analysis (1990–2023) across all age groups, providing a high-resolution map of where and in whom LRIs remain a primary threat, especially following the transmission disruptions caused by COVID-19 interventions.

Methods and Data

This study utilized a retrospective ecological design based on the Global Burden of Disease (GBD) 2023 database. Managed by the Institute for Health Metrics and Evaluation (IHME), this dataset aggregates information from vital registrations, household surveys, and clinical records worldwide.

Researchers analyzed three key metrics: Incidence, Mortality, and Disability-Adjusted Life Years (DALYs). To track long-term trends, Joinpoint Regression was used to calculate the Average Annual Percentage Change (AAPC), identifying whether the rate of decline has accelerated or stagnated over the 33-year study period.

The burden of LRIs follows a distinct U-shaped distribution across age cohorts. The highest incidence rates are found in the elderly (70+) and children under five. While pediatric mortality has decreased significantly due to vaccination and nutrition programs, the elderly population has seen a much slower rate of decline in both incidence and mortality. This suggests that "immune aging" and a lack of targeted geriatric vaccination strategies are creating a widening health gap.

Global LRI trends across different age groups (1990–2023).

Regional Disparities and Geographic Inequality

Geographic location remains a primary determinant of LRI burden. The African Region continues to face a disproportionate impact, with incidence rates nearly double the global average. This disparity is largely attributed to resource deficits, including shortages of medical personnel and lower vaccine coverage.

Trends of lower respiratory infections from 1990 to 2023 by WHO region.

Between 1990 and 2023, global LRI incidence dropped from 5,122 to 3,012 per 100,000 (AAPC of -1.57%). However, the absolute number of cases remains high in populous nations like India, China, and Nigeria. In 2023, the leading risk factors for LRI-related DALYs were child underweight, household air pollution, and child stunting.

Shifting Risk Factors

The study highlights a transition in environmental risks. While household air pollution from solid fuels is declining, ambient particulate matter pollution (outdoor smog) has risen in importance, now ranking as the 7th leading risk factor for LRI DALYs.

Limitations and Conclusion

The study's reliance on GBD modeling in regions with incomplete primary health data may affect local accuracy. Furthermore, the analysis does not account for the specific cultural drivers of risk factors like smoking or the granular success of individual national policies.

In conclusion, while global LRI rates are declining, the burden is increasingly concentrated in vulnerable age groups and low-income regions. Future public health efforts must prioritize geriatric vaccine coverage and combat child malnutrition in sub-Saharan Africa to achieve global health equity.

Summary updated

Abstract

<title>Abstract</title> Background Despite global progress in vaccination, antibiotic use, and sanitation, lower respiratory infections (LRIs) remain a substantial global burden. This study uses Global Burden of Disease 2023 data to inform LRIs control. Methods We quantified global and regional incidence, mortality, and DALYs for non-COVID-19 LRIs from 1990–2023, and assessed risks to LRI DALYs and deaths. Trend analyses used Joinpoint regression to estimate the AAPC. Results In 2023, global LRI incidence was 3,012.84 per 100,000, down since 1990 (AAPC − 1.57%; 95% CI − 1.70 to − 1.43). Africa had the highest incidence (5,848.11). From 1990–2023, incidence declined in Africa (− 1.11%; 95% CI − 1.22 to − 1.00) and Southeast Asia (− 1.03%; 95% CI − 1.11 to − 0.95). Top incidence countries: Kenya, Lesotho, Chad. By age, the ≥ 70 group had the highest incidence (12,531.69 per 100,000; UI 11,513.40–13,685.63), followed by under-5s (7,699.43; 6,660.02–8,786.62). Leading risk factors for LRI DALYs were child underweight (277.09), household air pollution from solid fuels (237.85), and child stunting (216.44). Conclusions The LRI burden declined 1990–2023, but disparities persist, with Africa and Southeast Asia bearing the highest burdens. Addressing child nutrition, air quality, and vaccination coverage—especially for vulnerable populations and high-risk regions—will promote health equity.
BibTeX
@inproceedings{mu2025global,
  author = {Caini Mu and Feng Liu and Lei Miao and Mengling Feng and Xiangyu Dang and Lixin Xie and Shanhong Fan and Li Xuan},
  title = {{Global, regional, and national burden of non-COVID-19 lower respiratory infections and risks, 1990–2023: a systematic analysis from GBD Study 2023}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-7536537/v1},
}
Figure